Hologic Announces Financial Results for First Quarter of Fiscal 2018
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
- AMD shares fall amid AI chip sector selloff
- JetBlue shares fall amid American results, fuel cost concerns
- Bloom Energy Corp. (BE) Tops Q3 EPS by 25c, Beats on Revenue; Offers FY26 Guidance
- S&P 500, Nasdaq end sharply lower as revived AI doubts ignite tech selloff
- LKQ posts Q3 loss, replaces CEO amid Europe struggles
Hologic (HOLX) PT Lowered to $48 at Canaccord Genuity Following 1Q Results
February 12, 2018 7:54 AM ESTCanaccord Genuity lowered its price target on Hologic (NASDAQ: HOLX) to $48.00 (from $50.00) while maintaining a Buy rating following the company's 1Q results. Revenues of ~$791M beat the Street's $786M, and adjusted EPS of $0.55 beat the Street's $0.50.
HOLX reiterated its prior FY'18... More



